10.23
price down icon0.63%   -0.065
after-market Dopo l'orario di chiusura: 10.24 0.005 +0.05%
loading

Novavax Inc Azioni (NVAX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
108.87%
147.14
70.44 239.24 666.65 88.31
Cost Of Revenue
2.83%
22.10
21.50 15.32 14.12 36.67
Gross Profit
155.44%
125.03
48.95 223.91 652.54 51.64
Operating Expenses
51.18%
110.81
226.97 122.84 137.03 182.72
Benefits Costs and Expenses
52.74%
129.24
273.48 131.79 146.81 161.89
Costs And Expenses
46.51%
132.91
248.46 138.17 151.14 219.39
Depreciation and Amortization
22.17%
5.125
6.585 7.563 8.34 12.52
Operating Income/Loss
107.99%
14.23
-178.02 101.07 515.51 -131.08
Income/Loss From Continuing Operations Before Tax
108.82%
17.90
-203.04 107.45 519.85 -73.58
Income Tax Expense/Benefit
157.23%
0.376
-0.657 0.946 1.20 7.449
Income/Loss From Continuing Operations After Tax
108.66%
17.53
-202.38 106.51 518.65 -81.03
Net Income/Loss
108.66%
17.53
-202.38 106.51 518.65 -81.03
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.89%
0.18
162.35 162.02 161.05 2.704
Diluted Average Shares
96.98%
4.908
162.35 177.22 177.62 2.704
Basic Earnings Per Share
108.80%
0.11
-1.25 0.66 3.22 -0.52
Diluted Earnings Per Share
104.00%
0.05
-1.25 0.62 2.93 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):